

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muramyl dipeptide (GO:0032495) | 5.07019185 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.04498989 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.04498989 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83975423 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68298336 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.49227644 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.43176974 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.29772832 |
| 9 | thymic T cell selection (GO:0045061) | 4.26009523 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.24987666 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20125282 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.15158025 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.12107825 |
| 14 | negative regulation of type 2 immune response (GO:0002829) | 4.06739036 |
| 15 | negative T cell selection (GO:0043383) | 3.92030451 |
| 16 | response to peptidoglycan (GO:0032494) | 3.89786690 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.88096583 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.86462521 |
| 19 | response to interleukin-15 (GO:0070672) | 3.83012943 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81650926 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81650926 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81650926 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 3.81650926 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81650926 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.81650926 |
| 26 | negative regulation of granulocyte differentiation (GO:0030853) | 3.80011395 |
| 27 | regulation of memory T cell differentiation (GO:0043380) | 3.79795132 |
| 28 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.78969890 |
| 29 | tolerance induction (GO:0002507) | 3.77725979 |
| 30 | T cell selection (GO:0045058) | 3.67427424 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.65357519 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.64629253 |
| 33 | mannose metabolic process (GO:0006013) | 3.64485031 |
| 34 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.57222740 |
| 35 | cellular response to interleukin-15 (GO:0071350) | 3.49189213 |
| 36 | leukocyte aggregation (GO:0070486) | 3.39242341 |
| 37 | NIK/NF-kappaB signaling (GO:0038061) | 3.31088068 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29271480 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.23279670 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21745119 |
| 41 | signal complex assembly (GO:0007172) | 3.21361855 |
| 42 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18687327 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.14205295 |
| 44 | actin nucleation (GO:0045010) | 3.11698328 |
| 45 | positive T cell selection (GO:0043368) | 3.09828976 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.09555393 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.07748876 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.05237818 |
| 49 | neutrophil activation (GO:0042119) | 3.00456913 |
| 50 | detection of bacterium (GO:0016045) | 2.99921611 |
| 51 | detection of other organism (GO:0098543) | 2.97846069 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.96785526 |
| 53 | negative regulation of innate immune response (GO:0045824) | 2.95141543 |
| 54 | positive regulation of interleukin-17 production (GO:0032740) | 2.90839858 |
| 55 | germinal center formation (GO:0002467) | 2.88765998 |
| 56 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87450469 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.85263020 |
| 58 | positive regulation of cholesterol efflux (GO:0010875) | 2.85091438 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 2.84595115 |
| 60 | activation of JUN kinase activity (GO:0007257) | 2.84536049 |
| 61 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83128146 |
| 62 | regulation of type 2 immune response (GO:0002828) | 2.82212156 |
| 63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81361488 |
| 64 | granulocyte activation (GO:0036230) | 2.81199632 |
| 65 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79359636 |
| 66 | negative regulation of bone resorption (GO:0045779) | 2.78924779 |
| 67 | regulation of tolerance induction (GO:0002643) | 2.78662806 |
| 68 | regulation of granulocyte differentiation (GO:0030852) | 2.73922301 |
| 69 | positive regulation of tolerance induction (GO:0002645) | 2.73491866 |
| 70 | regulation of B cell differentiation (GO:0045577) | 2.72473068 |
| 71 | detection of external biotic stimulus (GO:0098581) | 2.71065389 |
| 72 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.69536827 |
| 73 | positive regulation of Rap GTPase activity (GO:0032854) | 2.68295392 |
| 74 | negative regulation of interleukin-6 production (GO:0032715) | 2.68229819 |
| 75 | regulation of natural killer cell differentiation (GO:0032823) | 2.67813699 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 2.67753589 |
| 77 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67697703 |
| 78 | response to host immune response (GO:0052572) | 2.67697703 |
| 79 | positive regulation of B cell differentiation (GO:0045579) | 2.62357100 |
| 80 | response to type I interferon (GO:0034340) | 2.61529292 |
| 81 | negative regulation of phagocytosis (GO:0050765) | 2.60906592 |
| 82 | type I interferon signaling pathway (GO:0060337) | 2.60809853 |
| 83 | cellular response to type I interferon (GO:0071357) | 2.60809853 |
| 84 | T-helper cell differentiation (GO:0042093) | 2.52899810 |
| 85 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.52899810 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50547967 |
| 87 | response to host (GO:0075136) | 2.50547967 |
| 88 | response to host defenses (GO:0052200) | 2.50547967 |
| 89 | negative regulation of stress fiber assembly (GO:0051497) | 2.50383894 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.50223007 |
| 91 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.50008926 |
| 92 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49980882 |
| 93 | regulation of chromatin binding (GO:0035561) | 2.43849365 |
| 94 | regulation of interleukin-13 production (GO:0032656) | 2.43453517 |
| 95 | B cell homeostasis (GO:0001782) | 2.41897796 |
| 96 | cellular extravasation (GO:0045123) | 2.41284205 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 2.41216746 |
| 98 | positive regulation of natural killer cell activation (GO:0032816) | 2.41213499 |
| 99 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.38708807 |
| 100 | myeloid cell activation involved in immune response (GO:0002275) | 2.38481668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.72984819 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.16499834 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01055860 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.87328118 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.59856497 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50790413 |
| 7 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.46261919 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.42830473 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.41339220 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38957872 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.38168123 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.37104860 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36720993 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29457251 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.28266983 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.24504949 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.21077034 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18277743 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17913032 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14827891 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.12285880 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.07639541 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06259675 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04417238 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98494691 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94480925 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93961090 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.90918199 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86499608 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85180235 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83962672 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.83292475 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80508996 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77979794 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.77878485 |
| 36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75702605 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.75102853 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.74232713 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72508398 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69464207 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68549600 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66917746 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64627362 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61387585 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57616423 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56923809 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.54211614 |
| 48 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.51849360 |
| 49 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51577427 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50195483 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.49425093 |
| 52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47996625 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.46101235 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45587000 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43904401 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.43535255 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.40978524 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35947414 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32884061 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32837049 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32461324 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32400543 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32386925 |
| 64 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32016728 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31747886 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31022838 |
| 67 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29461298 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28349273 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28192778 |
| 70 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26345299 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26317454 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23365437 |
| 73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23263126 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22252219 |
| 75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20634725 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17757027 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16531278 |
| 78 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15204554 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14838192 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14448239 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13975901 |
| 82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13648366 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13259513 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12845003 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11658786 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11456811 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09630282 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09521997 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08506204 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05989053 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04953909 |
| 92 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03968359 |
| 93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02599624 |
| 94 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01949752 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01074299 |
| 96 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00892469 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00216310 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99433677 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97505326 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97349194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.40745204 |
| 2 | MP0003724_increased_susceptibility_to | 3.63646307 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.21095017 |
| 4 | MP0003303_peritoneal_inflammation | 3.18648723 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.73082953 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.69604548 |
| 7 | MP0001800_abnormal_humoral_immune | 2.55961193 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.55694423 |
| 9 | MP0005025_abnormal_response_to | 2.48639725 |
| 10 | MP0002419_abnormal_innate_immunity | 2.48173744 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.40271445 |
| 12 | MP0009278_abnormal_bone_marrow | 2.36473210 |
| 13 | MP0002723_abnormal_immune_serum | 2.33777787 |
| 14 | MP0002933_joint_inflammation | 2.28174259 |
| 15 | MP0001790_abnormal_immune_system | 2.27805177 |
| 16 | MP0005387_immune_system_phenotype | 2.27805177 |
| 17 | MP0006082_CNS_inflammation | 2.26498625 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.25813434 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.25700218 |
| 20 | MP0005671_abnormal_response_to | 2.25432511 |
| 21 | MP0000685_abnormal_immune_system | 2.23629895 |
| 22 | MP0009785_altered_susceptibility_to | 2.23164898 |
| 23 | MP0004947_skin_inflammation | 2.23053692 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.21505640 |
| 25 | MP0001819_abnormal_immune_cell | 2.20882314 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.20561796 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.08471823 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.04971099 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 2.02321316 |
| 30 | MP0002405_respiratory_system_inflammati | 1.95766767 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.83104239 |
| 32 | MP0002398_abnormal_bone_marrow | 1.79874405 |
| 33 | MP0008260_abnormal_autophagy | 1.76800961 |
| 34 | MP0000716_abnormal_immune_system | 1.75144482 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.73923385 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.71285991 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.62032445 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.61972832 |
| 39 | MP0003828_pulmonary_edema | 1.61812814 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.56630235 |
| 41 | MP0004381_abnormal_hair_follicle | 1.55961753 |
| 42 | MP0000858_altered_metastatic_potential | 1.54678471 |
| 43 | MP0002722_abnormal_immune_system | 1.50233455 |
| 44 | MP0004510_myositis | 1.48969451 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.48389173 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.46256503 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.42550699 |
| 48 | MP0002429_abnormal_blood_cell | 1.40786296 |
| 49 | MP0009840_abnormal_foam_cell | 1.40001939 |
| 50 | MP0009764_decreased_sensitivity_to | 1.38922637 |
| 51 | MP0003866_abnormal_defecation | 1.36260903 |
| 52 | MP0002009_preneoplasia | 1.34623477 |
| 53 | MP0005451_abnormal_body_composition | 1.33060258 |
| 54 | MP0002132_abnormal_respiratory_system | 1.32093196 |
| 55 | MP0001873_stomach_inflammation | 1.30781100 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.30206853 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.30206853 |
| 58 | MP0004130_abnormal_muscle_cell | 1.29517289 |
| 59 | MP0005390_skeleton_phenotype | 1.28940910 |
| 60 | MP0001851_eye_inflammation | 1.26564958 |
| 61 | MP0008469_abnormal_protein_level | 1.23506272 |
| 62 | MP0003279_aneurysm | 1.21071296 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.19770004 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 1.15331317 |
| 65 | MP0003878_abnormal_ear_physiology | 1.15331317 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.14842644 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.07141343 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.03678224 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 0.98370032 |
| 70 | MP0008874_decreased_physiological_sensi | 0.94488756 |
| 71 | MP0005166_decreased_susceptibility_to | 0.94045312 |
| 72 | MP0001853_heart_inflammation | 0.93154977 |
| 73 | MP0002006_tumorigenesis | 0.90759746 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.89728805 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.87326180 |
| 76 | MP0004883_abnormal_blood_vessel | 0.85927607 |
| 77 | MP0000249_abnormal_blood_vessel | 0.85482462 |
| 78 | MP0003075_altered_response_to | 0.82589579 |
| 79 | MP0003795_abnormal_bone_structure | 0.78882145 |
| 80 | MP0006138_congestive_heart_failure | 0.78224152 |
| 81 | MP0005310_abnormal_salivary_gland | 0.77882282 |
| 82 | MP0005375_adipose_tissue_phenotype | 0.77671379 |
| 83 | MP0002254_reproductive_system_inflammat | 0.74972541 |
| 84 | MP0000767_abnormal_smooth_muscle | 0.72737263 |
| 85 | MP0000604_amyloidosis | 0.72427356 |
| 86 | MP0000013_abnormal_adipose_tissue | 0.72289258 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.71676514 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.70278358 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.70080367 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.69866103 |
| 91 | MP0000371_diluted_coat_color | 0.69093123 |
| 92 | MP0003091_abnormal_cell_migration | 0.68849217 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.68277964 |
| 94 | MP0009115_abnormal_fat_cell | 0.68251774 |
| 95 | MP0003329_amyloid_beta_deposits | 0.66077784 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 0.65851071 |
| 97 | MP0009763_increased_sensitivity_to | 0.65374636 |
| 98 | MP0005164_abnormal_response_to | 0.64679643 |
| 99 | MP0001849_ear_inflammation | 0.64640729 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.62693323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.80236022 |
| 2 | Spontaneous hematomas (HP:0007420) | 3.91778824 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.77130879 |
| 4 | Myositis (HP:0100614) | 3.76024362 |
| 5 | Inflammation of the large intestine (HP:0002037) | 3.66440359 |
| 6 | Gastrointestinal inflammation (HP:0004386) | 3.64287004 |
| 7 | T lymphocytopenia (HP:0005403) | 3.60011289 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.57051229 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.53664599 |
| 10 | Colitis (HP:0002583) | 3.28050520 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.27071446 |
| 12 | Orchitis (HP:0100796) | 3.23405078 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.21486646 |
| 14 | Obstructive lung disease (HP:0006536) | 3.15788612 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15788612 |
| 16 | J-shaped sella turcica (HP:0002680) | 3.13691143 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.02273348 |
| 18 | Increased IgE level (HP:0003212) | 3.01467645 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.00939547 |
| 20 | Abnormality of T cell number (HP:0011839) | 2.98946162 |
| 21 | Pustule (HP:0200039) | 2.87380286 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.85487590 |
| 23 | Optic neuritis (HP:0100653) | 2.85487590 |
| 24 | Granulocytopenia (HP:0001913) | 2.84778633 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78857253 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78857253 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78857253 |
| 28 | Meningitis (HP:0001287) | 2.78127738 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70956475 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70956475 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70956475 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69734908 |
| 33 | Mucopolysacchariduria (HP:0008155) | 2.69734908 |
| 34 | Nasal polyposis (HP:0100582) | 2.67769903 |
| 35 | Encephalitis (HP:0002383) | 2.67591038 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66979732 |
| 37 | Slow saccadic eye movements (HP:0000514) | 2.64225681 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.60443743 |
| 39 | Increased IgM level (HP:0003496) | 2.58269536 |
| 40 | Obstructive sleep apnea (HP:0002870) | 2.54774242 |
| 41 | Epistaxis (HP:0000421) | 2.54356476 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.54132434 |
| 43 | Chest pain (HP:0100749) | 2.53819985 |
| 44 | Abnormality of the nasal mucosa (HP:0000433) | 2.52806805 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.52007520 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51339736 |
| 47 | Vasculitis (HP:0002633) | 2.50494744 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.49736176 |
| 49 | Recurrent viral infections (HP:0004429) | 2.48546567 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.46978410 |
| 51 | Gingival bleeding (HP:0000225) | 2.44464696 |
| 52 | Cellulitis (HP:0100658) | 2.43429184 |
| 53 | Recurrent skin infections (HP:0001581) | 2.36928493 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36509841 |
| 55 | Panhypogammaglobulinemia (HP:0003139) | 2.35198949 |
| 56 | Abnormality of T cells (HP:0002843) | 2.32852925 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31226000 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31226000 |
| 59 | Pulmonary embolism (HP:0002204) | 2.25492664 |
| 60 | Myopathic facies (HP:0002058) | 2.25319187 |
| 61 | Broad face (HP:0000283) | 2.24702435 |
| 62 | Papilloma (HP:0012740) | 2.24557454 |
| 63 | Verrucae (HP:0200043) | 2.24557454 |
| 64 | Abnormality of the fingertips (HP:0001211) | 2.21868054 |
| 65 | Gingivitis (HP:0000230) | 2.20550271 |
| 66 | Stomatitis (HP:0010280) | 2.19215571 |
| 67 | Eosinophilia (HP:0001880) | 2.19177811 |
| 68 | Agammaglobulinemia (HP:0004432) | 2.16699817 |
| 69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.15196886 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.15022998 |
| 71 | Urticaria (HP:0001025) | 2.13048183 |
| 72 | Easy fatigability (HP:0003388) | 2.11328533 |
| 73 | Increased serum ferritin (HP:0003281) | 2.11148055 |
| 74 | Cervical subluxation (HP:0003308) | 2.09884890 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.09510667 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.08843432 |
| 77 | Leukocytosis (HP:0001974) | 2.08562524 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.07992811 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 2.06473228 |
| 80 | Hypochromic anemia (HP:0001931) | 2.06180589 |
| 81 | Global brain atrophy (HP:0002283) | 2.05373933 |
| 82 | Hematochezia (HP:0002573) | 2.04106264 |
| 83 | Abnormality of eosinophils (HP:0001879) | 2.03428976 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.02404711 |
| 85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.02142441 |
| 86 | Ocular albinism (HP:0001107) | 1.99557229 |
| 87 | Joint stiffness (HP:0001387) | 1.97828845 |
| 88 | Keratoconjunctivitis sicca (HP:0001097) | 1.97729005 |
| 89 | Glomerulopathy (HP:0100820) | 1.97645147 |
| 90 | Polygenic inheritance (HP:0010982) | 1.97129470 |
| 91 | Deformed sella turcica (HP:0002681) | 1.96551772 |
| 92 | Sepsis (HP:0100806) | 1.96357129 |
| 93 | Keratoconjunctivitis (HP:0001096) | 1.94166631 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 1.92824709 |
| 95 | Conical tooth (HP:0000698) | 1.92284476 |
| 96 | Stomach cancer (HP:0012126) | 1.91802040 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 1.89938504 |
| 98 | Hypertriglyceridemia (HP:0002155) | 1.87634487 |
| 99 | B lymphocytopenia (HP:0010976) | 1.85466708 |
| 100 | Amyloidosis (HP:0011034) | 1.85181734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.20038782 |
| 2 | RIPK4 | 3.17018459 |
| 3 | MAP3K14 | 2.85732132 |
| 4 | MAP4K1 | 2.85465015 |
| 5 | PRPF4B | 2.80690869 |
| 6 | TRIB3 | 2.69701460 |
| 7 | IKBKE | 2.67566622 |
| 8 | TBK1 | 2.41805148 |
| 9 | TXK | 2.29240667 |
| 10 | MAP2K2 | 2.26823291 |
| 11 | MAP2K3 | 2.14051097 |
| 12 | GRK6 | 2.11114802 |
| 13 | SIK1 | 2.03164036 |
| 14 | TNK2 | 1.97709697 |
| 15 | IRAK4 | 1.83525588 |
| 16 | TYK2 | 1.76171068 |
| 17 | BLK | 1.69697887 |
| 18 | IKBKB | 1.66931538 |
| 19 | TESK2 | 1.66022945 |
| 20 | ZAP70 | 1.65098421 |
| 21 | CSK | 1.62341361 |
| 22 | KDR | 1.43596595 |
| 23 | JAK1 | 1.42623655 |
| 24 | SIK3 | 1.41239956 |
| 25 | ICK | 1.37931594 |
| 26 | MAP3K6 | 1.35603726 |
| 27 | FES | 1.33063013 |
| 28 | EPHB1 | 1.31856280 |
| 29 | SIK2 | 1.30726888 |
| 30 | BTK | 1.30698171 |
| 31 | TESK1 | 1.25611106 |
| 32 | MAP3K3 | 1.25443955 |
| 33 | MAP3K13 | 1.18202289 |
| 34 | ITK | 1.14630171 |
| 35 | KIT | 1.04746971 |
| 36 | MARK2 | 1.03925123 |
| 37 | LCK | 1.03137709 |
| 38 | MAPK7 | 1.02712529 |
| 39 | BMPR2 | 1.01697363 |
| 40 | SYK | 1.00704648 |
| 41 | PKN2 | 0.99921051 |
| 42 | CHUK | 0.98618213 |
| 43 | PTK6 | 0.98505437 |
| 44 | TTN | 0.96447065 |
| 45 | RPS6KC1 | 0.95500524 |
| 46 | RPS6KL1 | 0.95500524 |
| 47 | PDPK1 | 0.94739677 |
| 48 | DYRK1B | 0.93618458 |
| 49 | MAP3K11 | 0.93473024 |
| 50 | HIPK2 | 0.91821162 |
| 51 | PRKD2 | 0.91156334 |
| 52 | HCK | 0.90429573 |
| 53 | IRAK3 | 0.90058309 |
| 54 | JAK3 | 0.89296069 |
| 55 | PDK1 | 0.88395646 |
| 56 | RPS6KA2 | 0.87919094 |
| 57 | MAP3K5 | 0.87774538 |
| 58 | RPS6KA6 | 0.86486098 |
| 59 | FGFR4 | 0.85691726 |
| 60 | CAMKK1 | 0.81330174 |
| 61 | SMG1 | 0.80659268 |
| 62 | MAP2K6 | 0.78821708 |
| 63 | TAOK1 | 0.77162338 |
| 64 | LYN | 0.75084573 |
| 65 | RIPK1 | 0.73179045 |
| 66 | CDC42BPA | 0.72970171 |
| 67 | MAP3K7 | 0.72675919 |
| 68 | NEK6 | 0.72552164 |
| 69 | JAK2 | 0.68655884 |
| 70 | NME2 | 0.67238118 |
| 71 | MARK3 | 0.63686310 |
| 72 | RET | 0.62618360 |
| 73 | MAPK4 | 0.61258153 |
| 74 | TAOK2 | 0.61207357 |
| 75 | MAPK15 | 0.60595269 |
| 76 | RPS6KA4 | 0.60502892 |
| 77 | MAPK12 | 0.60246415 |
| 78 | PRKCQ | 0.59496358 |
| 79 | CSF1R | 0.59475975 |
| 80 | MAPK11 | 0.58046275 |
| 81 | IRAK2 | 0.57584398 |
| 82 | PIM2 | 0.57570248 |
| 83 | CDK6 | 0.56347517 |
| 84 | PIM1 | 0.54895762 |
| 85 | CDK4 | 0.53219132 |
| 86 | TLK1 | 0.52673916 |
| 87 | STK38 | 0.51920862 |
| 88 | GRK7 | 0.51189360 |
| 89 | FYN | 0.50277178 |
| 90 | RPS6KA1 | 0.49968920 |
| 91 | MAP3K1 | 0.49026140 |
| 92 | IRAK1 | 0.48311071 |
| 93 | LRRK2 | 0.47480072 |
| 94 | CDK12 | 0.42396296 |
| 95 | FGR | 0.39217379 |
| 96 | MAPK3 | 0.39139169 |
| 97 | MATK | 0.37762268 |
| 98 | MAP2K1 | 0.35915441 |
| 99 | BMX | 0.34950058 |
| 100 | SGK3 | 0.34852077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.83794726 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.76263725 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.42070929 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.27039433 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13008104 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.08350253 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97739787 |
| 8 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.92922721 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91411894 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.86372129 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68945280 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65605583 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62803880 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.62102412 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61419056 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.51718399 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.48624852 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46054827 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.44891535 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44790432 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.42849874 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41319123 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40857372 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34395652 |
| 25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32652836 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32209535 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.30687013 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28682253 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26395547 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26065914 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20451280 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.19839766 |
| 33 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.18818604 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18772888 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.18346407 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.18152565 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17676417 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14106917 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13308306 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.12569019 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.12057762 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.11997998 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.11302584 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.09138297 |
| 45 | Allograft rejection_Homo sapiens_hsa05330 | 1.07963272 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.04406098 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.03339223 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03072238 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.02291911 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.97930346 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95757487 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.92843840 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92781184 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92125482 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91633347 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88341553 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82684394 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82644842 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.82567937 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82147683 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81275355 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78915749 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78064403 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76918352 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75813016 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.75728931 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75581267 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75280971 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.73841260 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72179188 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71965883 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71241434 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70819847 |
| 74 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69345089 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69063681 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68821034 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68737232 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67694920 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66808947 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66687614 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66495517 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66131208 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60943903 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60883945 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.55892649 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54756869 |
| 87 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54433998 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54398187 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53500748 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53359088 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53294250 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.52362507 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52343819 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50248765 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48652757 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.47966772 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44485775 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.43749807 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41664089 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40924688 |

